|Bid||61.90 x 0|
|Ask||61.84 x 0|
|Day's Range||59.75 - 62.93|
|52 Week Range||31.81 - 76.68|
|Beta (3Y Monthly)||5.04|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||76.91|
Canopy Rivers said late Wednesday it had appointed current president Narbé Alexandrian to the chief executive job. Until Wednesday, Canopy Growth Corp. CEO Bruce Linton served as interim CEO of Rivers. Linton will remain on Rivers' board as chairman. Canopy Rivers is the publicly traded venture capital-type unit of Canopy Growth, the world's largest weed company. Canopy Rivers stock closed up 2.9% during the regular session Wednesday and Canopy Growth stock closed up 2.3%. The S&P 500 index fell 0.3% Wednesday.
Tweed, Canada's top cannabis producer, is excited to announce the May 23rd grand opening of their Meadow Lake retail location with a celebration of fun, education and most importantly, community love! Legal cannabis is new to many consumers but we've been cutting our teeth as a medical producer for years so we can help suggest strains and educate on the different ways to consume cannabis.
Canadian cannabis producer Canopy Growth said it is buying This Works, a London-based skin care company, for around $55 million.
Why Canopy Growth Is on the Rise TodayCanopy Growth acquires skincare companyOn May 22, Canopy Growth (WEED) (CGC) announced its acquisition of This Works, a natural wellness company based in London, England, for a total of 73.8 million Canadian
Cannabis stocks were mostly higher Wednesday, as investors digested the latest deal in the sector, Canopy Growth Corp.’s acquisition of a U.K. skin care company.
Canopy Growth Corp said on Wednesday it would buy skincare company This Works for C$73.8 million ($55.2 million), adding beauty and sleep products to the Canadian weed producer's portfolio of cannabis oil, hemp and medical capsules. London-based This Works, set up in 2003 by a former beauty director of Vogue UK and yoga teacher, makes pillow sprays that help users sleep faster, moisturizers to reduce wrinkles, body oils and eye-care products, according to its website. Canopy Growth said the acquisition fits with its strategy of expanding internationally and would help develop CBD-infused products and brands for the global beauty and wellness space.
How Do Cannabis Stocks' Valuations Stack Up in May?(Continued from Prior Part)Investing in the cannabis sectorThe cannabis sector has had its ups and downs in the past month. The trend has mostly been flat to downwards-trending for most of the
Canopy Growth: Analysts' Views in May(Continued from Prior Part)Canopy Growth’s valuationCanopy Growth (WEED) (CGC) is one of the few stocks that has traded at premium valuation multiples compared to its peers like Aurora Cannabis (ACB), Aphria
shares were up 0.6% in premarket trading after the company announced that it purchased London-based skincare and sleep solutions company This Works for C$73.8 million. The company offers a range of natural skincare and sleep solution products, including a deep sleep pillow spray, morning expert hyaluronic serum and a dry leg oil. This Works CEO Anna Persaud will stay on as head of business operations after the acquisition with Canopy Growth supporting the company's current operations with an accelerated focus on global expansion and product development, including skincare and sleep solution products infused with CBD.
Canopy Growth: Analysts' Views in MayCanopy GrowthCanopy Growth (WEED) (CGC) has been among the strongest cannabis bets for investors. In the past few months, more analysts have initiated coverage on the stock. In May, one more analyst initiated
Canopy Growth Corp (NYSE: CGC ) is expanding in the wellness industry with the acquisition of London-based skincare and well-being company This Works . What Happened The acquisition will be done in all-cash. ...
Aurora Cannabis Inc. shares rose Tuesday, after the Canadian company said it has entered a multiyear, multimillion-dollar agreement with mixed martial arts organization UFC to research the effect of hemp-derived CBD products on athlete recovery and wellness.
Canopy Growth Corp. , the world's biggest cannabis company by market capitalization, said Wednesday it's acquiring London-based skincare company This Works for 43 million pounds ($54 million) in cash. This Works offers a range of skincare and sleep products, including deep sleep pillow spray, morning expert hyaluronic serum and skin deep dry leg oil. The deal "is a key aspect of a multi-faceted hemp and CBD strategy as Canopy Growth continues to build upon its vertically-integrated production and marketing platform, that currently includes thousands of acres of hemp production across several continents, hundreds of millions of dollars of capital investment into hemp-derived CBD production and processing, rapid expansion across the European Union and other key regions, and the introduction of new CBD-infused products and brands to the global beauty, wellness, and sleep solution space," Canopy said in a statement. This Works Chief Executive Anna Persaud will remain at the helm of the business once the deal has closed. Canopy is armed with a more than $4 billion balance sheet courtesy of an investment from Corona beer maker Constellation Brands Inc. last year. Canopy shares were up 0.7% premarket, and have gained 67% in 2019, while the S&P 500 has gained 14%.
SMITHS FALLS, ON and LONDON, May 22, 2019 /PRNewswire/ - Canopy Growth Corporation (WEED.TO) (CGC) (the "Company" or "Canopy Growth") has finalized an all-cash transaction to acquire This Works for a purchase price of £43 million (CDN $73.8 million). Founded in 2004, This Works has cemented itself as a global leader in natural skincare and sleep solutions with a devout customer base spanning 35 countries. Headquartered in London, England, This Works offers a range of high-quality natural skincare and sleep solution products that have rewarded the company with a loyal following of customers purchasing their best-known products including deep sleep pillow spray, morning expert hyaluronic serum, and skin deep dry leg oil.
Canopy Growth Corporation (NYSE: CGC ) announced the appointment of its Executive Vice President of Finance, Mike Lee, to its executive leadership team as acting Chief Financial Officer, effective June ...
Canadian marijuana manufacturer Canopy Growth appoints former Constellation Brands' senior executive Mike Lee as the company's acting chief financial officer.
TORONTO , May 21, 2019 /CNW/ - Canopy Rivers Inc. ("Canopy Rivers" or the "Company") (RIV.V) (CNPOF) is pleased to share that its portfolio company, Agripharm Corp. ("Agripharm"), has received its outdoor cultivation license from Health Canada. "We are pleased to see Agripharm diversify its operations and increase its growing capacity with the grant of this outdoor cultivation licence," said Oliver Dufourmantelle, Chief Operating Officer of Canopy Rivers. Founded in 2013, Agripharm is home to both the first cannabis production facility built from the ground up and the first supercritical CO2 extraction lab in Canada .
Canopy Growth Corp. , the biggest cannabis company by market cap, said Tuesday it has appointed Mike Lee as interim chief financial officer effective June 1. Lee was previously senior vice president and CFO for Constellation Brands Inc.'s $3 billion wine and spirits business. Lee will become permanent CFO once Health Canada completes a security clearance that is required for all officers of the company. Constellation Brands invested $4 billion in Canopy last year, arming the Smiths Falls, Ontario-based company with a war chest to expand its business. Tim Saunders, the former CFO, will remain at the company in an advisory role. U.S.-listed shares of Canopy rose 1.5% premarket, and have gained 42.6% in the last 12 months, while the S&P 500 has gained 3.9%.
SMITHS FALLS, ON, May 21, 2019 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (WEED.TO) (CGC) is pleased to announce the appointment of Mike Lee to its executive leadership team in the acting role of Chief Financial Officer (CFO), effective June 1, 2019. Mike's permanent role as CFO will commence upon receiving Health Canada security clearance required for all Officers and Directors of the Company.